Shanghai HEP Pharmaceutical Co., Ltd.
Quick facts
Phase 3 pipeline
- Placebo of Hepalatide
This is a placebo control formulation used in clinical trials and does not exert any active pharmacological effect.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: